Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Board Changes

6 May 2021 15:06

RNS Number : 8269X
Cenkos Securities PLC
06 May 2021
 

6 May 2021

Cenkos Securities plc

("Cenkos" or the "Company")

 

Board Changes

 

Further to the announcement released on 9 December 2020 relating to the retirement of Jim Durkin, Chief Executive Officer, at the forthcoming Annual General Meeting, and the appointment of Julian Morse as the new Chief Executive Officer, the Board is pleased to confirm that Julian's appointment has now received regulatory approval from the Financial Conduct Authority. Julian will be appointed to the position of Chief Executive Officer which will take place immediately following the Company's Annual General Meeting on 12 May 2021.

 

The Board is also pleased to announce that Jeremy Osler's appointment as an Executive Director of the Company, has also received regulatory approval from the Financial Conduct Authority. Jeremy will join the Board immediately following the Company's Annual General Meeting on 12 May 2021.

 

Commenting on the Board changes, Lisa Gordon Non-Executive Chairman said:

 

"On behalf of the Board I would like to pay tribute to Jim Durkin, who has been central to the creation and development of Cenkos over the past 16 years. I have hugely enjoyed working with Jim over the last 12 months on the blueprint for Cenkos' ongoing success and we wish him well in his forthcoming retirement.

 

The appointment of Julian Morse as Chief Executive Officer and wider changes to the senior management team across the Firm, including the appointment of Jeremy Osler to the Board as Executive Director, creates a strong team to lead and take the business forward." 

 

For further information, please contact:

Cenkos Securities plc

Lisa Gordon, Non-Executive Chairman

Julian Morse, Executive Director Tel: 0207 397 8900

 

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser Tel: 0203 368 3552

 

The Nisse Consultancy - Public relations

Jason Nisse Tel: 07769 688618

Andrew Garfield Tel: 07974 982337

 

 

Additional Information 

The only change to the information previously supplied on 9 December 2020 in respect of Jeremy Osler's appointment as required under Schedule 2(g) of the AIM Rules is that his current interest in the Company's share capital is now made up of:  

 

49,627 Ordinary shares held in an ordinary managed account.

93,470 Ordinary shares held in accordance with the terms and conditions of Company's Deferred Bonus Scheme.

8,274 Ordinary shares held in the Company's Share Incentive Plan.

Option over 44,698 Ordinary shares held under the Company's Save As You Earn Plan. These options are at 40.27pence. These options expire on 30 June 2024.

Option over 40,000 Ordinary shares held under the Company's Share Option Plan. These options are at 73.50 pence, subject to a performance condition, and vest in April 2024.

A nil cost Option over 510,000 Ordinary shares held under the Company's Long Term Incentive Plan. These options are subject to a performance condition and vest equally in April 2024, 2025 and 2026.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAFMITMTMMBJB
Date   Source Headline
15th Apr 20199:48 amRNSForm 8.5 (EPT/NON-RI)
12th Apr 201911:05 amRNSForm 8.5 (EPT/NON-RI)
11th Apr 20199:57 amRNSForm 8.5 (EPT/NON-RI)
10th Apr 201912:36 pmRNSPDMR Shareholding
10th Apr 201912:35 pmRNSEBT Share Transfer
8th Apr 20195:05 pmRNSEBT Share Purchase
5th Apr 20192:30 pmRNSEBT Share Purchase
5th Apr 20191:57 pmRNSAnnual Report and Annual General Meeting Notice
2nd Apr 201912:27 pmRNSEBT Share Purchase
1st Apr 201912:08 pmRNSEBT Share Purchase
1st Apr 201910:16 amRNSDirectorate Changes
26th Mar 201912:33 pmRNSDirector/PDMR Shareholding
26th Mar 20197:00 amRNSAnnual Results for the year ended 31 December 2018
13th Mar 201910:54 amRNSEBT Share Purchase
11th Mar 20197:00 amRNSDirectorate Change
19th Feb 20191:05 pmRNSEBT Share Purchase
7th Feb 201910:19 amRNSEBT Share Purchase
29th Jan 201910:08 amRNSEBT Share Purchase
28th Jan 201911:11 amRNSEBT Share Purchase
25th Jan 201910:44 amRNSEBT Share Purchase
23rd Jan 20194:14 pmRNSEBT Share Purchase Plan
19th Dec 20183:50 pmRNSTrading Update
12th Dec 20183:56 pmRNSEBT Share Purchase
12th Dec 20187:45 amRNSAcquisition of Business
12th Dec 20187:00 amRNSDirectorate Changes
28th Nov 20184:09 pmRNSEBT Share Purchase
28th Nov 201810:00 amRNSPDMR Shareholding
7th Nov 201810:35 amRNSEBT Share Purchase
6th Nov 20185:10 pmRNSAward of shares under SIP and Directors' Dealings
6th Nov 20181:33 pmRNSEBT Share Purchase
5th Nov 20187:00 amRNSBoard Changes
31st Oct 20184:29 pmRNSBoard Change
16th Oct 20185:14 pmRNSBlock listing Interim Review
9th Oct 20187:00 amRNSBoard Change
3rd Oct 201810:02 amRNSEBT Share Purchase
18th Sep 20187:00 amRNSInterim Results for six months ended 30 June 2018
10th Sep 201812:00 pmRNSEBT Share Purchase
7th Sep 201810:19 amRNSEBT Share Purchase
16th Aug 201812:19 pmRNSEBT Share Purchase
6th Aug 201812:02 pmRNSEBT Share Purchase
1st Aug 20187:00 amRNSAcquisition of business
24th Jul 201811:06 amRNSSecond Price Monitoring Extn
24th Jul 201811:00 amRNSPrice Monitoring Extension
24th Jul 20187:00 amRNSTrading Update
23rd Jul 20185:33 pmRNSEBT Share Purchase
20th Jul 20187:00 amRNSChange of Adviser
3rd Jul 20189:02 amRNSForm 8.5 (EPT/NON-RI)
2nd Jul 20189:47 amRNSForm 8.5 (EPT/NON-RI)
29th Jun 201810:31 amRNSForm 8.5 (EPT/NON-RI)
25th Jun 201811:50 amRNSEBT Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.